Ligbas, Rosemarie H.
HRN: 14-15-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2023
CO-AMOXICLAV 625MG (TAB)
06/24/2023
06/27/2023
PO
625mg
Q8hrs
Fracture
Waiting Final Action